Live Breaking News & Updates on Trisalus infusion system

Stay updated with breaking news from Trisalus infusion system. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific Meeting

– New safety and feasibility data from Phase 1/1b PERIO-03 trial for locally advanced pancreatic cancer supports further development of the novel TriSalus Infusion System for therapeutic delivery. ....

Texas , United-states , Trisalu-trinav , Stevenc-katz , Linkedin , Centers-for-medicare-medicaid-services , University-of-texas-md-anderson-cancer-center , Nasdaq , Twitter , Society-of-interventional-radiology-annual-scientific-meeting , Current-medical-research , Trisalus-life-sciences

TriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

– New data from PERIO-03 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of a TLR9 agonist in pancreatic tumors –

. ....

Texas , United-states , Trisalu-trinav , Michaels-lee , Stevenc-katz , Twitter , Nasdaq , Trisalus-life-sciences , Exchange-commission , Society-of-immunotherapy , University-of-texas-md-anderson-cancer-center , Linkedin

TriSalus Life Sciences, Inc. Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma At the Society for Immunotherapy of Cancer Annual Meeting

TriSalus Life Sciences®? Inc. announced initial positive safety and feasibility data from a Phase 1 trial at the Society of Immunotherapy for Cancer 2023 Annual Meeting. TriSalus is studying an. ....

Trisalus-life-sciences , Society-of-immunotherapy , Pressure-enabled-drug , Trisalus-infusion-system , Enabled-regional-immuno-oncology , Pressure-enabled-regional-immuno-oncology , Infusion-system , Markets ,

TriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

03.11.2023 - TriSalus Life Sciences Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today announced initial positive safety and . Seite 1 ....

Texas , United-states , Michaels-lee , University-of-texas-md-anderson-cancer-center , Trisalus-infusion-system , Medical-oncology ,